胃肠病学门诊手术中心市场（按服务、适应症、治疗水平、患者人口统计、应用、最终用户和所有者划分）——2025-2032 年全球预测

预计到 2032 年，胃肠病学门诊手术中心市场将成长 135.5 亿美元，复合年增长率为 8.49%。

主要市场统计数据
基准年2024年	70.5亿美元
预计2025年	76.6亿美元
预测年份：2032年	135.5亿美元
复合年增长率（%）	8.49%

门诊消化内科手术中心简介：强调临床范围和操作的多样性以及以患者为中心的服务的演变

在临床创新、患者对便利性的偏好以及简化的护理路径的推动下，胃肠门诊手术中心 (ASC) 模式正在重塑诊断和治疗程序的交付。近年来，内视镜技术、微创手术技术和手术全期管理的进步扩大了可在门诊安全实施的手术范围。因此，专业的胃肠病学机构正在发展成为高容量的枢纽，提供频谱的胶囊内视镜检查、大肠镜检查以及上下消化道手术，同时保持精简的观察和当日手术服务。

它们以多种形式运营，包括诊所、医生办公室、医院附属单位和独立的 ASC，所有权模式也从公司所有平台到独立和医院附属中心不等。患者群体涵盖儿童、成人和老年人，需要量身定制的临床通讯协定、復健途径和手术全期支持。此外，诊断测试、内视镜检查和治疗性介入（例如内视镜黏膜切除术和黏膜下剥离术）越来越多地在传统住院环境之外进行。胃肠病 ASC 将这些功能与以患者为中心的设计相结合，是现代医疗保健服务的重要组成部分，提供高价值、低成本的替代方案，并专注于吞吐量、安全性和患者体验。

临床创新、报销变化和劳动力动态如何加速门诊胃肠病学护理的转型

在技​​术创新、医疗服务模式革新和员工团队不断发展的推动下，胃肠道门诊手术中心的格局正在改变。高解析度影像、胶囊内视镜和新一代内视镜正在提高诊断效率，而内视镜黏膜切除术、黏膜下剥离术和精细切除术等先进治疗方案则正在扩大当日手术的范围。同时，随着围手术期方案和麻醉技术缩短患者恢復时间，腹腔镜胃肠手术、括约肌切开术和疝气修补术等手术全期手术方法正在转移到门诊平台。

支付改革和基于价值的合约正在加速低访问量、高容量手术从住院医院向独立医疗服务中心 (ASC) 和诊所环境的迁移，奖励医疗机构的优化。远端医疗和远距术前评估工具正在提高诊疗效率并降低爽约率，而整合的电子健康记录和程序分析则实现了持续的品质改进和即时病例管理。劳动力动态，尤其是对接受过高级内视镜培训的临床医生、手术全期护理师和专业技术人员的需求，正在推动对培训和保留计画的投资。最后，患者对便利性、透明度和快速访问的期望加剧了竞争，迫使医疗机构透过护理协调、当日手术途径和增强型復健通讯协定来实现差异化。

评估 2025 年关税趋势对门诊胃肠病服务和资本规划的累积营运和采购影响

2025 年关税和贸易相关政策的变化为胃肠外科 ASC 的供应链、资本规划和筹资策略带来了新的考虑因素。许多诊断和治疗设备、耗材和内视镜配件依赖全球製造网络，进口关税的增加和贸易摩擦可能会增加购买成本并导致前置作业时间的变化。对于专注于资本密集型升级（例如购买先进的内视镜和微创手术系统）的医疗保健组织来说，关税带来的成本压力要求重新评估更换週期、租赁与购买决策以及总拥有成本的评估。

累积影响不仅限于设备成本，还延伸至库存管理和合约行为。医疗机构正在透过多元化供应商组合、协商固定价格、多年期合约以及探索区域製造伙伴关係来降低风险。与大型医院系统相比，独立的医疗服务中心 (ASC) 通常采购规模较小，它们可能会寻求集团采购或策略联盟来恢復谈判优势。同时，与关税相关的价格上涨可能会加速那些寻求扩大营运规模以吸收成本衝击的机构之间的整合。无法跟上不断上涨的投入成本的报销框架将给报销额较低的门诊手术带来利润压力，促使领导者优化病例组合、加强编码和文檔实践，并寻求符合付款人优先事项的更高价值治疗性介入。最终，在关税不确定性的环境下，策略性和差异化的供应链反应，结合积极主动的财务建模，对于维持服务的连续性和持续的创新投资至关重要。

综合細項分析揭示了胃肠外科 ASC 的服务类型、护理水平和所有权模式如何决定策略重点

细緻的细分视角揭示了胃肠外科ASC领域中临床机会与营运重点的交会点。按服务进行分析，诊断能力涵盖胶囊内视镜、大肠镜、食道内视镜、柔性乙状结肠镜和上消化道内视镜等，提供高通量工作流程，支援早期发现和简化转诊。同时，内视镜黏膜切除术、内视镜黏膜下剥离术、痔疮结扎术、息肉切除术和硬化疗法等治疗服务，创造了明确的门诊治疗途径，从而减少住院治疗。

大肠直肠癌筛检、胃肠道感染疾病、发炎性肠道疾病和肝硬化的优先排序分别需要不同的诊断演算法、术前和术后风险分层以及术后追踪。护理水平轴——观察与当日手术——决定了人员配置模式、恢復室设计和排程方法，以在确保病人安全的同时最大限度地提高诊疗效率。儿科患者需要适合年龄的镇静和以家庭为中心的工作流程；成人患者需要筛检和慢性病管理；老年患者需要强化的术前评估和恢復通讯协定，并考虑到併发症。

应用主导的细分进一步明确了诊断检测、内视镜实验室和治疗性介入之间的资源分配，从而影响资本投资重点和临床能力发展。诊所/诊所、医院和独立医疗服务中心 (ASC) 之间的最终用户差异决定了转诊流程、病例复杂性以及与付款人和供应商的谈判能力。最后，所有权结构（企业自有平台、独立中心或医院附属单位）会影响策略方向，包括成长、规模和整合。每种结构在资本取得、营运自主权和临床通讯协定标准化能力方面都有所权衡。这些细分视角提供了一个全面的框架，用于将临床服务与财务策略和患者需求相结合。

对美洲、欧洲、中东、非洲和亚太地区报销和能力建设的区域动态进行比较和战略考虑

区域动态显着影响全球的营运模式、先进流程采用曲线和监管合规要求。在美洲，成熟的报销基础设施和强劲的门诊病人转型趋势，推动着专注于内视镜检查的ASC和独立外科中心的快速发展，尤其註重结直肠癌筛检计画和注重效率的当日手术工作流程。北美中心通常利用整合采购和成熟的认证框架来标准化品质并降低单次手术成本，市场参与企业正在探索捆绑支付安排并与付款人网路合作。

在欧洲、中东和非洲，报销系统和监管要求的差异导致采用率参差不齐。西欧体系通常强调整合护理路径和公私合营，使附设医院的ASC能够扩展诊断和治疗内视镜计画。相较之下，该地区的新兴市场为能力建设、技术转移以及对发炎性肠道疾病管理和胃肠道感染控制等高影响力服务的定向投资提供了机会。监管差异也会影响设备註册时间表和跨境筹资策略。

受选择性治疗需求成长、人口老化以及私人医疗基础设施不断扩张的推动，亚太地区正在快速普及微创和内视镜治疗技术。一些国家已加强本地製造能力，降低国际贸易中断带来的风险，并支持竞争性定价。然而，临床医生培训、报销改革以及城乡医疗可近性差距仍然存在。有效扩大门诊胃肠病学治疗需要独特的策略，将人力资源开发、基于远端医疗的分诊和分阶段的资金部署相结合。

推动创新和规模发展的设备製造商、ASC 营运商和综合医疗系统之间的竞争动态和伙伴关係策略

门诊胃肠病学服务的竞争格局由设备製造商、技术创新者、ASC运营商和透过伙伴关係追求临床差异化和规模化的综合医疗系统决定。设备和耗材供应商优先考虑一次性产品，这些产品不仅耐用、影像清晰、吞吐量经济，还能降低交叉污染的风险。供应商将硬体与分析、远端监控和服务等级协定结合，为ASC营运商提供优化运作和程序效率的工具。

为因应这项挑战，ASC营运商和医疗系统正与技术合作伙伴携手合作，进行有针对性的收购以扩大地域覆盖范围，并投资于能够集中处理复杂内视镜手术的卓越中心模式。策略性买家也专注于垂直整合机会，例如整合门诊网络，该网络包含术前评估平台、集中调度和标准化临床通讯协定，旨在推动一致性和规模经济。新的服务模式强调医生团体与企业之间的合资企业，以平衡临床控制和资金取得。在整个生态系统中，最成功的组织是那些能够平衡临床创新与严谨的营运执行，并利用供应链弹性、临床医生参与度和付款人关係来维持成长和品质的组织。

为高阶主管领导提供可行的策略指南，以加强临床能力、多样化供应链并获取门诊胃肠病学护理的价值。

门诊胃肠病学领导者应采取积极主动、多管齐下的策略，在降低下行风险的同时，获得临床和经济价值。首先，优先投资于能够实现高临床效益和高操作效率的诊断和治疗内视镜技术，并辅以结构化的培训计划，以提高临床医生的能力。其次，透过多供应商承包、区域製造伙伴关係以及参与联合采购安排，实现采购多元化，以减轻供应侧衝击和关税相关成本波动带来的影响。第三，透过扩展当日手术通讯协定、加强术前远距远端保健评估以及优化观察路径来改善服务组合和吞吐量，从而在不影响安全性的情况下减少住院时间。

此外，对于大肠癌筛检和慢性病管理奖励等高容量服务，应与付款方和医疗系统合作，制定基于价值的方案，将品质和成本控制激励机制结合起来。投资整合排程、手术全期记录和分析功能的数位基础设施，以监控疗效并识别效率提升机会。对于所有权集团，应评估合併和合资模式，以达到竞争性采购和资本取得所需的规模。最后，优先考虑患者体验和透明度，以加强转诊关係并抢占市场份额。在日益以消费者主导的世界中，清晰地沟通手术预期、恢復时间表和费用，可以使医疗中心脱颖而出。

透明的混合调查方法将一手资料和二手资料与情境分析相结合，为 ASC 提供可行的见解

本执行摘要所依据的研究结合了主要研究和次要研究，以确保其严谨性和有效性。主要研究包括对临床医生、ASC 经理、供应链专业人员和付款人的结构化访谈，旨在提供关于流程、采购优先顺序和报销之间相互作用的定性见解。次要研究涵盖同行评审的临床文献、监管指南、设备性能文件以及支持临床趋势和技术能力的公开意见书。

我们的分析方法将定性观察结果与营运指标（例如吞吐量、病例组合复杂度和资源利用率）进行三角测量，从而清晰地描绘当前的医疗实践模式。为了突出适合每个细分市场的差异化策略，我们根据服务、适应症、护理水平、患者人口统计、应用、最终用户和所有权结构进行了細項分析。为了进行区域比较，我们利用政策分析和采用指标来绘製美洲、欧洲、中东和非洲以及亚太地区的准备状态。不确定性（尤其是在贸易政策和报销变化方面），我们采用基于情境的分析来概述可行的营运应对措施和财务敏感性。我们的调查方法强调透明度、可重复性和可操作性，以便为策略决策提供参考。

为什么策略性临床投资和供应链弹性决定了胃肠外科 ASC 的长期成功

门诊胃肠病中心处于临床创新、营运工程和不断变化的消费者期望的交汇点，既带来了重大机会，也带来了独特的执行挑战。诊断和治疗内视镜技术的进步，加上手术全期护理的改进，使得更广泛的手术能够转向当日和基于观察的模式，从而改善了可及性并降低了医疗总成本。然而，外部压力，包括波动的关税、供应链影响以及不同的地区报销框架，需要采取策略性应对措施，在临床能力投资与采购惯例之间取得平衡。

成功的组织机构应使其服务组合与人群需求保持一致，投资于临床医生培训和数位化工作流程，实现供应链多元化以保持韧性，并寻求在不牺牲临床自主权的情况下提供资金和规模的伙伴关係结构。透过专注于以结果、患者体验和总成本衡量的价值，医疗保健提供者可以将其门诊胃肠病中心定位为扩展诊断和治疗性介入的首选医疗机构。周到的执行、严格的品管和适应性策略将决定哪些中心能够从门诊胃肠病治疗的转变中获益。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

• 先进内视镜成像技术的快速应用将缩短手术时间并改善治疗效果。
• 整合人工智慧演算法，提高门诊中心息肉检测与诊断的准确性
• 扩大当日出院通讯协定，辅以镇静剂替代品和简化的术前评估
• 向基于价值的报销模式转型，以激励品质措施并降低胃肠病学 ASC 的再入院率
• 实施术前和术后咨询的远端医疗平台可提高病患参与度和营运效率
• 投资可携式视镜和移动大肠镜检查装置，扩大农村和服务不足患者群体的诊疗覆盖率

第六章：2025年美国关税的累积影响

第七章：人工智慧的累积影响，2025年

8. 胃肠病学门诊手术中心市场（按服务）

• 诊断服务
  • 胶囊内视镜
  • 大肠镜检查
  • 食道测压
  • 柔性乙状结肠镜检查
  • 上消化道内视镜检查
• 外科服务
  • 减重手术
  • 胆囊切除术
  • 大肠直肠手术
  • 腹股沟疝气修补术
  • 腹腔镜胃肠手术
  • 括约肌切开术
• 治疗服务
  • 内视镜黏膜切除术
  • 内视镜黏膜下剥离术
  • 痔疮结扎术
  • 切除术
  • 硬化疗法

9. 胃肠病学门诊手术中心市场（按适应症）

• 大肠癌筛检
• 胃肠道感染疾病
• 发炎性肠道疾病
• 肝硬化

10. 胃肠病学门诊手术中心市场（依护理等级）

• 观察
• 当日手术

第 11 章胃肠病学门诊手术中心市场（依病患属性）

• 成人
• 老年人
• 孩子们

第 12 章胃肠病学门诊手术中心市场（按应用）

• 诊断测试
• 内视镜检查
• 治疗性介入

第 13 章。胃肠病学门诊手术中心市场（按最终用户）

• 诊所和医生办公室
• 医院
• 独立 ASC

14. 胃肠病学门诊手术中心市场（按所有权类型）

• 公司所有权
• 自主型
• 医院相关

15. 胃肠病学门诊手术中心市场（按地区）

• 美洲
  • 北美洲
  • 拉丁美洲
• 欧洲、中东和非洲
  • 欧洲
  • 中东
  • 非洲
• 亚太地区

第 16 章胃肠病学门诊手术中心市场（按类别）

• ASEAN
• GCC
• EU
• BRICS
• G7
• NATO

第 17 章。按国家/地区分類的胃肠病学门诊手术中心市场

• 美国
• 加拿大
• 墨西哥
• 巴西
• 英国
• 德国
• 法国
• 俄罗斯
• 义大利
• 西班牙
• 中国
• 印度
• 日本
• 澳洲
• 韩国

第十八章竞争格局

• 2024年市占率分析
• 2024年FPNV定位矩阵
• 竞争分析
  • Alfa Surgery Center, LLC
  • Envision Healthcare Corporation
  • GE HealthCare Technologies Inc.
  • Ontario Advanced Surgery Center
  • Tenet Healthcare Corporation
  • Universal Health Services, Inc.
  • Covenant Physician Partners
  • Regent Surgical
  • Gastro Health LLC
  • Ohio Gastroenterology Group Inc.
  • HCA Healthcare, Inc.
  • SCA Health
  • United Digestive
  • Alabama Digestive Health Endoscopy Center（AL）
  • Shelby Ambulatory Surgery
  • Baptist Health South Florida, Inc.
  • Gulf Coast Endoscopy Center
  • Jupiter Outpatient Surgery Center, LLC
  • SOUTH BROWARD ENDOSCOPY, LLC
  • The Outpatient Center of Boynton Beach
  • Liberty Endoscopy Center
  • OHIO GASTROENTEROLOGY & LIVER INSTITUTE and GASTRO HEALTH
  • Inova McLean Ambulatory Surgery Center
  • Gastroenterology Associates Endoscopy Center
  • Athens Gastroenterology Center

The Gastroenterology Ambulatory Surgery Center Market is projected to grow by USD 13.55 billion at a CAGR of 8.49% by 2032.

KEY MARKET STATISTICS
Base Year [2024]	USD 7.05 billion
Estimated Year [2025]	USD 7.66 billion
Forecast Year [2032]	USD 13.55 billion
CAGR (%)	8.49%

An incisive introduction to ambulatory gastroenterology centers highlighting clinical scope operational diversity and patient-centric service evolution

The ambulatory surgery center (ASC) model for gastroenterology is reshaping how diagnostic and therapeutic procedures are delivered, driven by clinical innovation, patient preference for convenience, and efficiencies in care pathways. In recent years, advances in endoscopic technology, minimally invasive surgical techniques, and perioperative management have expanded the range of procedures safely performed in outpatient settings. As a result, facilities that concentrate on gastroenterology are evolving into high-capacity hubs that deliver capsule endoscopy, colonoscopy, and a wide spectrum of upper and lower gastrointestinal procedures while maintaining streamlined observation and same-day surgery services.

Operational structures vary across clinics and physicians' offices, hospital-affiliated units, and independent ASCs, while ownership models range from corporation-owned platforms to freestanding and hospital-aligned centers. Patient demographics span pediatric care through adult and geriatric populations, requiring tailored clinical protocols, recovery pathways, and perioperative support. Moreover, the application landscape incorporates diagnostic tests, endoscopy procedures, and therapeutic interventions such as endoscopic mucosal resection and submucosal dissection, which are increasingly performed outside traditional inpatient settings. This convergence of capabilities and patient-centered design positions gastroenterology ASCs as a pivotal part of modern care delivery, delivering high-value, lower-cost alternatives that emphasize throughput, safety, and patient experience.

How converging clinical innovations reimbursement shifts and workforce dynamics are accelerating outpatient gastroenterology care transformation

The landscape of gastroenterology ambulatory surgery centers is undergoing transformative shifts driven by technological innovation, care delivery redesign, and workforce evolution. High-resolution imaging, capsule endoscopy, and next-generation endoscopes are improving diagnostic yield while advanced therapeutic options such as endoscopic mucosal resection, submucosal dissection, and refined polypectomy techniques are expanding the therapeutic scope possible in same-day settings. Concurrently, minimally invasive surgical approaches including laparoscopic gastrointestinal surgeries and targeted procedures like sphincterotomy and hernia repair are migrating toward outpatient platforms as perioperative protocols and anesthesia techniques reduce recovery times.

Payment reforms and value-based contracting are incentivizing site-of-care optimization, accelerating the transfer of lower-acuity, high-volume procedures from inpatient hospitals to independent ASCs and clinic-based settings. Telehealth and remote preoperative assessment tools are enhancing throughput and reducing no-show rates, while integrated electronic health records and procedural analytics enable continuous quality improvement and real-time case management. Workforce dynamics-particularly the need for advanced endoscopy-trained clinicians, perioperative nurses, and specialized technicians-are prompting investments in training and retention programs. Lastly, patient expectations for convenience, transparency, and rapid access have intensified competition, compelling providers to differentiate through care coordination, same-day surgery pathways, and enhanced recovery protocols that collectively shift the balance of care toward ambulatory environments.

Assessing the cumulative operational and procurement consequences of 2025 tariff dynamics on ambulatory gastroenterology services and capital planning

Policy shifts related to tariffs and trade in 2025 have introduced a new set of considerations for supply chains, capital planning, and procurement strategies for gastroenterology ASCs. Many diagnostic and therapeutic devices, disposables, and endoscopy accessories rely on global manufacturing networks; increases in import duties or trade frictions can raise acquisition costs and introduce variability into lead times. For providers focused on capital-intensive upgrades such as purchasing advanced endoscopes or minimally invasive surgical systems, tariff-induced cost pressures require re-evaluation of replacement cycles, leasing versus purchasing decisions, and total cost of ownership assessments.

The cumulative effect extends beyond device cost to inventory management and contracting behavior. Facilities are responding by diversifying supplier portfolios, negotiating fixed-price multi-year contracts, and exploring regional manufacturing partnerships to mitigate exposure. Independent ASCs, with typically narrower purchasing scale compared to large hospital systems, may seek group purchasing arrangements or strategic alliances to restore bargaining parity. At the same time, tariff-related price increases can accelerate consolidation as organizations pursue operational scale to absorb cost shocks. Reimbursement frameworks that do not keep pace with rising input costs will place margin pressure on lower-reimbursed procedures performed in ambulatory settings, prompting leadership to optimize case mix, enhance coding and documentation practices, and pursue higher-value therapeutic interventions that align with payer priorities. Ultimately, a strategic and differentiated supply-chain response combined with proactive financial modeling will be essential for maintaining service continuity and preserving investment in innovation under tariff uncertainty.

Integrated segmentation analysis revealing how service types indications levels of care and ownership models shape strategic priorities in gastroenterology ASCs

A nuanced segmentation view illuminates where clinical opportunity and operational focus intersect across the gastroenterology ASC landscape. When analyzed by services, diagnostic capabilities extend from capsule endoscopy and colonoscopy to esophageal manometry, flexible sigmoidoscopy, and upper endoscopy, feeding a high-throughput workflow that supports early detection and streamlined referrals. Surgical services encompass bariatric procedures, cholecystectomy, colorectal surgery, inguinal hernia repair, and a growing array of laparoscopic gastrointestinal surgeries, while therapeutic offerings such as endoscopic mucosal resection, endoscopic submucosal dissection, hemorrhoid ligation, polypectomy, and sclerotherapy create pathways for definitive outpatient care that reduce inpatient demand.

Viewing the environment through the lens of indication highlights priorities in colorectal cancer screening, gastrointestinal infections, inflammatory bowel diseases, and liver cirrhosis, each requiring distinct diagnostic algorithms, peri-procedural risk stratification, and post-procedure follow-up. The level of care axis-observation versus same-day surgery-shapes staffing patterns, recovery room design, and scheduling practices to maximize throughput while preserving patient safety. Patient demographics also drive differential service models: pediatric cases demand age-appropriate sedation and family-centered workflows, adult pathways emphasize screening and chronic disease management, and geriatric populations require comorbidity-aware preoperative evaluation and enhanced recovery protocols.

Application-driven segmentation further clarifies resource allocation between diagnostic tests, endoscopy suites, and therapeutic interventions, influencing capital expenditure priorities and clinical competency development. End-user distinctions across clinics and physicians' offices, hospitals, and independent ASCs determine referral flows, case complexity, and negotiation leverage with payers and suppliers. Finally, ownership models-corporation-owned platforms, freestanding centers, and hospital-affiliated units-affect strategic orientation toward growth, scale, and integration; each structure brings trade-offs in capital access, operational autonomy, and the ability to standardize clinical protocols. Together, these segmentation lenses provide a comprehensive framework for aligning clinical services with financial strategy and patient needs.

Comparative regional dynamics and strategic considerations shaping adoption reimbursement and capacity building across Americas EMEA and Asia-Pacific

Regional dynamics substantially influence operational models, adoption curves for advanced procedures, and regulatory-compliance requirements across the globe. In the Americas, mature reimbursement infrastructures and a strong trend toward outpatient migration have driven rapid adoption of endoscopy-focused ASCs and independent surgical centers, with particular emphasis on colorectal cancer screening programs and efficiency-driven same-day surgery workflows. North American centers often leverage consolidated purchasing and established accreditation frameworks to standardize quality and drive down per-procedure costs, while market participants experiment with bundled-payment arrangements and partnerships with payer networks.

Across Europe, the Middle East, and Africa, heterogeneous reimbursement regimes and regulatory conditions create a mosaic of adoption rates. Western European systems frequently emphasize integrated care pathways and public-private collaboration, enabling hospital-affiliated ASCs to scale diagnostic and therapeutic endoscopy programs. In contrast, emerging markets within the region present opportunities for capacity-building, technology transfer, and targeted investments in high-impact services such as management of inflammatory bowel disease and gastrointestinal infection control. Regulatory variability also influences device registration timelines and cross-border procurement strategies.

The Asia-Pacific region demonstrates rapid uptake of minimally invasive and endoscopic therapeutic techniques, driven by rising demand for elective procedures, growing geriatric populations, and expanding private healthcare infrastructure. Local manufacturing footprints are strengthening in several countries, which can mitigate exposure to international trade disruptions and support competitive pricing. However, disparities in clinician training, reimbursement reform, and urban-rural access persist, requiring tailored strategies that combine workforce development, telehealth-enabled triage, and phased capital deployment to scale ambulatory gastroenterology capabilities effectively.

Competitive dynamics and partnership strategies among device makers ASC operators and integrated health systems driving innovation and operational scale

The competitive landscape for gastroenterology ambulatory services is defined by device manufacturers, technology innovators, ASC operators, and integrated health systems that pursue scale through clinical differentiation and partnerships. Device and consumable suppliers are prioritizing durability, image clarity, and disposable options that reduce cross-contamination risk while enabling cost-effective throughput. Vendors that couple hardware with analytics, remote monitoring, and service-level agreements provide ASC operators with tools to optimize uptime and procedural efficiency.

ASC operators and health systems are responding by forging alliances with technology partners, pursuing targeted acquisitions to expand geographic reach, and investing in center-of-excellence models that concentrate complex endoscopic procedures. Strategic purchasers are also focusing on vertical integration opportunities, such as combined ambulatory networks that include preoperative assessment platforms, centralized scheduling, and standardized clinical protocols to drive consistency and economies of scale. Emerging service models emphasize joint ventures between physician groups and corporate entities to balance clinical control with capital access. Across the ecosystem, the most successful organizations are those that balance clinical innovation with disciplined operational execution, leveraging supply-chain resilience, clinician engagement, and payer relationships to sustain growth and quality.

Actionable strategic directives for executive leaders to strengthen clinical capabilities diversify supply chains and capture value in ambulatory gastroenterology

Leaders in ambulatory gastroenterology should adopt a proactive, multi-dimensional strategy to capture clinical and economic value while mitigating downside risks. First, prioritize investment in diagnostic and therapeutic endoscopy capabilities that deliver high clinical yield and procedural efficiency, supported by structured training programs to scale clinician competency. Second, diversify procurement through multi-supplier contracts, regional manufacturing partnerships, and participation in cooperative purchasing arrangements to reduce exposure to supply-side shocks and tariff-related cost volatility. Third, refine service mix and throughput by expanding same-day surgery protocols, enhancing preoperative telehealth assessments, and optimizing observation pathways to reduce length of stay without compromising safety.

Additionally, pursue partnerships with payers and health systems to develop value-based arrangements for high-volume interventions such as colorectal cancer screening and chronic disease management programs, thereby aligning incentives for quality and cost control. Invest in digital infrastructure that integrates scheduling, perioperative documentation, and analytics to monitor outcomes and identify efficiency opportunities. For ownership groups, evaluate consolidation and joint-venture models to achieve the scale necessary for competitive procurement and capital access. Finally, emphasize patient experience and transparency to strengthen referral relationships and capture market share; clear communication about procedure expectations, recovery timelines, and cost can differentiate centers in increasingly consumer-driven care pathways.

A transparent mixed-methods research methodology combining primary interviews secondary evidence and scenario analysis to produce actionable ASC insights

The research underpinning this executive summary synthesizes primary and secondary investigative approaches to ensure rigor and relevance. Primary inputs included structured interviews with clinicians, ASC administrators, supply-chain professionals, and payers, providing qualitative insights into procedural workflows, procurement priorities, and reimbursement interactions. Secondary research encompassed peer-reviewed clinical literature, regulatory guidance, device performance documentation, and public filings to corroborate clinical trends and technological capabilities.

Analytical techniques employed triangulate qualitative observations with operational metrics such as throughput, case-mix complexity, and resource utilization to generate a coherent picture of current practice patterns. Segmentation analyses were conducted across services, indications, levels of care, patient demographics, applications, end-users, and ownership structures to surface differentiated strategies appropriate to each segment. Regional comparisons drew on policy analyses and adoption indicators to map readiness across the Americas, Europe, the Middle East and Africa, and Asia-Pacific. Where uncertainty exists-particularly around trade policy and reimbursement changes-scenario-based analysis was used to outline plausible operational responses and financial sensitivities. The methodology emphasizes transparency, reproducibility, and actionable insights tailored for strategic decision-making.

Concluding synthesis on why strategic alignment clinical investment and supply chain resilience determine long-term success for gastroenterology ASCs

Ambulatory gastroenterology centers sit at the intersection of clinical innovation, operational engineering, and changing consumer expectations, presenting both significant opportunities and clear execution challenges. Advances in diagnostic and therapeutic endoscopy, coupled with improvements in perioperative care, enable a broader set of procedures to transition to same-day and observation-based models, improving access and reducing total cost of care. However, external pressures including tariff volatility, supply-chain exposure, and uneven regional reimbursement frameworks require strategic responses that balance investment in clinical capability with disciplined operational and procurement practices.

Organizations that succeed will be those that align service portfolios with population needs, invest in clinician training and digital workflows, diversify supply chains to maintain resilience, and pursue partnership structures that provide capital and scale without sacrificing clinical autonomy. By focusing on value-measured through outcomes, patient experience, and total cost-providers can position ambulatory gastroenterology centers as a preferred site of care for a growing range of diagnostic and therapeutic interventions. Thoughtful execution, rigorous quality management, and adaptive strategy will determine which centers capitalize on the shift toward outpatient gastrointestinal care.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Rapid adoption of advanced endoscopic imaging techniques reducing procedure times and improving outcomes
• 5.2. Integration of artificial intelligence algorithms to enhance polyp detection and diagnostic accuracy in ambulatory centers
• 5.3. Expansion of same-day discharge protocols supported by sedation alternatives and streamlined preoperative assessments
• 5.4. Shift toward value based reimbursement models incentivizing quality metrics and reduced readmission rates in gastroenterology ASCs
• 5.5. Implementation of telehealth platforms for pre and post procedure consultations boosting patient engagement and operational efficiency
• 5.6. Investment in portable endoscopy and mobile colonoscopy units expanding access to rural and underserved patient populations

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Gastroenterology Ambulatory Surgery Center Market, by Services

• 8.1. Diagnostic Services
  • 8.1.1. Capsule Endoscopy
  • 8.1.2. Colonoscopy
  • 8.1.3. Esophageal Manometry
  • 8.1.4. Flexible Sigmoidoscopy
  • 8.1.5. Upper Endoscopy
• 8.2. Surgical Services
  • 8.2.1. Bariatric Surgery
  • 8.2.2. Cholecystectomy
  • 8.2.3. Colorectal Surgery
  • 8.2.4. Inguinal Hernia Repair
  • 8.2.5. Laparoscopic Gastrointestinal Surgeries
  • 8.2.6. Sphincterotomy
• 8.3. Therapeutic Services
  • 8.3.1. Endoscopic Mucosal Resection
  • 8.3.2. Endoscopic Submucosal Dissection
  • 8.3.3. Hemorrhoid Ligation
  • 8.3.4. Polypectomy
  • 8.3.5. Sclerotherapy

9. Gastroenterology Ambulatory Surgery Center Market, by Indication

• 9.1. Colorectal Cancer Screening
• 9.2. Gastrointestinal Infections
• 9.3. Inflammatory Bowel Diseases
• 9.4. Liver Cirrhosis

10. Gastroenterology Ambulatory Surgery Center Market, by Level of Care

• 10.1. Observation
• 10.2. Same-Day Surgery

11. Gastroenterology Ambulatory Surgery Center Market, by Patient Demographic

• 11.1. Adults
• 11.2. Geriatric
• 11.3. Pediatric

12. Gastroenterology Ambulatory Surgery Center Market, by Application

• 12.1. Diagnostic Tests
• 12.2. Endoscopy
• 12.3. Therapeutic Interventions

13. Gastroenterology Ambulatory Surgery Center Market, by End-User

• 13.1. Clinics & Physicians' Offices
• 13.2. Hospitals
• 13.3. Independent ASCs

14. Gastroenterology Ambulatory Surgery Center Market, by Ownership

• 14.1. Corporation-Owned
• 14.2. Freestanding
• 14.3. Hospital-Affiliated

15. Gastroenterology Ambulatory Surgery Center Market, by Region

• 15.1. Americas
  • 15.1.1. North America
  • 15.1.2. Latin America
• 15.2. Europe, Middle East & Africa
  • 15.2.1. Europe
  • 15.2.2. Middle East
  • 15.2.3. Africa
• 15.3. Asia-Pacific

16. Gastroenterology Ambulatory Surgery Center Market, by Group

• 16.1. ASEAN
• 16.2. GCC
• 16.3. European Union
• 16.4. BRICS
• 16.5. G7
• 16.6. NATO

17. Gastroenterology Ambulatory Surgery Center Market, by Country

• 17.1. United States
• 17.2. Canada
• 17.3. Mexico
• 17.4. Brazil
• 17.5. United Kingdom
• 17.6. Germany
• 17.7. France
• 17.8. Russia
• 17.9. Italy
• 17.10. Spain
• 17.11. China
• 17.12. India
• 17.13. Japan
• 17.14. Australia
• 17.15. South Korea

18. Competitive Landscape

• 18.1. Market Share Analysis, 2024
• 18.2. FPNV Positioning Matrix, 2024
• 18.3. Competitive Analysis
  • 18.3.1. Alfa Surgery Center, LLC
  • 18.3.2. Envision Healthcare Corporation
  • 18.3.3. GE HealthCare Technologies Inc.
  • 18.3.4. Ontario Advanced Surgery Center
  • 18.3.5. Tenet Healthcare Corporation
  • 18.3.6. Universal Health Services, Inc.
  • 18.3.7. Covenant Physician Partners
  • 18.3.8. Regent Surgical
  • 18.3.9. Gastro Health LLC
  • 18.3.10. Ohio Gastroenterology Group Inc.
  • 18.3.11. HCA Healthcare, Inc.
  • 18.3.12. SCA Health
  • 18.3.13. United Digestive
  • 18.3.14. Alabama Digestive Health Endoscopy Center (AL)
  • 18.3.15. Shelby Ambulatory Surgery
  • 18.3.16. Baptist Health South Florida, Inc.
  • 18.3.17. Gulf Coast Endoscopy Center
  • 18.3.18. Jupiter Outpatient Surgery Center, LLC
  • 18.3.19. SOUTH BROWARD ENDOSCOPY, LLC
  • 18.3.20. The Outpatient Center of Boynton Beach
  • 18.3.21. Liberty Endoscopy Center
  • 18.3.22. OHIO GASTROENTEROLOGY & LIVER INSTITUTE and GASTRO HEALTH
  • 18.3.23. Inova McLean Ambulatory Surgery Center
  • 18.3.24. Gastroenterology Associates Endoscopy Center
  • 18.3.25. Athens Gastroenterology Center

LIST OF FIGURES

• FIGURE 1. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, 2018-2032 (USD MILLION)
• FIGURE 2. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SERVICES, 2024 VS 2032 (%)
• FIGURE 3. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SERVICES, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 4. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY INDICATION, 2024 VS 2032 (%)
• FIGURE 5. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 6. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY LEVEL OF CARE, 2024 VS 2032 (%)
• FIGURE 7. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY LEVEL OF CARE, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 8. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY PATIENT DEMOGRAPHIC, 2024 VS 2032 (%)
• FIGURE 9. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY PATIENT DEMOGRAPHIC, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 10. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
• FIGURE 11. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 12. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY END-USER, 2024 VS 2032 (%)
• FIGURE 13. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 14. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY OWNERSHIP, 2024 VS 2032 (%)
• FIGURE 15. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY OWNERSHIP, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 16. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 17. AMERICAS GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 18. NORTH AMERICA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 19. LATIN AMERICA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 21. EUROPE GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 22. MIDDLE EAST GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 23. AFRICA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 24. ASIA-PACIFIC GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 25. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 26. ASEAN GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 27. GCC GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 28. EUROPEAN UNION GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 29. BRICS GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 30. G7 GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 31. NATO GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 32. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 33. GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 34. GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

• TABLE 1. GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, 2018-2024 (USD MILLION)
• TABLE 4. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, 2025-2032 (USD MILLION)
• TABLE 5. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
• TABLE 6. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
• TABLE 7. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY DIAGNOSTIC SERVICES, 2018-2024 (USD MILLION)
• TABLE 8. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY DIAGNOSTIC SERVICES, 2025-2032 (USD MILLION)
• TABLE 9. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY DIAGNOSTIC SERVICES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 10. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY DIAGNOSTIC SERVICES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 11. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY DIAGNOSTIC SERVICES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 12. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY DIAGNOSTIC SERVICES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 13. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY DIAGNOSTIC SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 14. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY DIAGNOSTIC SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 15. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY CAPSULE ENDOSCOPY, BY REGION, 2018-2024 (USD MILLION)
• TABLE 16. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY CAPSULE ENDOSCOPY, BY REGION, 2025-2032 (USD MILLION)
• TABLE 17. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY CAPSULE ENDOSCOPY, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 18. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY CAPSULE ENDOSCOPY, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 19. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY CAPSULE ENDOSCOPY, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 20. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY CAPSULE ENDOSCOPY, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 21. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY COLONOSCOPY, BY REGION, 2018-2024 (USD MILLION)
• TABLE 22. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY COLONOSCOPY, BY REGION, 2025-2032 (USD MILLION)
• TABLE 23. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY COLONOSCOPY, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 24. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY COLONOSCOPY, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 25. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY COLONOSCOPY, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 26. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY COLONOSCOPY, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 27. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY ESOPHAGEAL MANOMETRY, BY REGION, 2018-2024 (USD MILLION)
• TABLE 28. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY ESOPHAGEAL MANOMETRY, BY REGION, 2025-2032 (USD MILLION)
• TABLE 29. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY ESOPHAGEAL MANOMETRY, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 30. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY ESOPHAGEAL MANOMETRY, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 31. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY ESOPHAGEAL MANOMETRY, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 32. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY ESOPHAGEAL MANOMETRY, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 33. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY FLEXIBLE SIGMOIDOSCOPY, BY REGION, 2018-2024 (USD MILLION)
• TABLE 34. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY FLEXIBLE SIGMOIDOSCOPY, BY REGION, 2025-2032 (USD MILLION)
• TABLE 35. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY FLEXIBLE SIGMOIDOSCOPY, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 36. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY FLEXIBLE SIGMOIDOSCOPY, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 37. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY FLEXIBLE SIGMOIDOSCOPY, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 38. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY FLEXIBLE SIGMOIDOSCOPY, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 39. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY UPPER ENDOSCOPY, BY REGION, 2018-2024 (USD MILLION)
• TABLE 40. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY UPPER ENDOSCOPY, BY REGION, 2025-2032 (USD MILLION)
• TABLE 41. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY UPPER ENDOSCOPY, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 42. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY UPPER ENDOSCOPY, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 43. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY UPPER ENDOSCOPY, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 44. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY UPPER ENDOSCOPY, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 45. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SURGICAL SERVICES, 2018-2024 (USD MILLION)
• TABLE 46. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SURGICAL SERVICES, 2025-2032 (USD MILLION)
• TABLE 47. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SURGICAL SERVICES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 48. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SURGICAL SERVICES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 49. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SURGICAL SERVICES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 50. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SURGICAL SERVICES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 51. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SURGICAL SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 52. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SURGICAL SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 53. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY BARIATRIC SURGERY, BY REGION, 2018-2024 (USD MILLION)
• TABLE 54. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY BARIATRIC SURGERY, BY REGION, 2025-2032 (USD MILLION)
• TABLE 55. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY BARIATRIC SURGERY, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 56. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY BARIATRIC SURGERY, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 57. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY BARIATRIC SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 58. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY BARIATRIC SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 59. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY CHOLECYSTECTOMY, BY REGION, 2018-2024 (USD MILLION)
• TABLE 60. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY CHOLECYSTECTOMY, BY REGION, 2025-2032 (USD MILLION)
• TABLE 61. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY CHOLECYSTECTOMY, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 62. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY CHOLECYSTECTOMY, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 63. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY CHOLECYSTECTOMY, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 64. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY CHOLECYSTECTOMY, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 65. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY COLORECTAL SURGERY, BY REGION, 2018-2024 (USD MILLION)
• TABLE 66. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY COLORECTAL SURGERY, BY REGION, 2025-2032 (USD MILLION)
• TABLE 67. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY COLORECTAL SURGERY, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 68. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY COLORECTAL SURGERY, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 69. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY COLORECTAL SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 70. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY COLORECTAL SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 71. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY INGUINAL HERNIA REPAIR, BY REGION, 2018-2024 (USD MILLION)
• TABLE 72. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY INGUINAL HERNIA REPAIR, BY REGION, 2025-2032 (USD MILLION)
• TABLE 73. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY INGUINAL HERNIA REPAIR, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 74. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY INGUINAL HERNIA REPAIR, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 75. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY INGUINAL HERNIA REPAIR, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 76. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY INGUINAL HERNIA REPAIR, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 77. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY LAPAROSCOPIC GASTROINTESTINAL SURGERIES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 78. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY LAPAROSCOPIC GASTROINTESTINAL SURGERIES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 79. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY LAPAROSCOPIC GASTROINTESTINAL SURGERIES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 80. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY LAPAROSCOPIC GASTROINTESTINAL SURGERIES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 81. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY LAPAROSCOPIC GASTROINTESTINAL SURGERIES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 82. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY LAPAROSCOPIC GASTROINTESTINAL SURGERIES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 83. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SPHINCTEROTOMY, BY REGION, 2018-2024 (USD MILLION)
• TABLE 84. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SPHINCTEROTOMY, BY REGION, 2025-2032 (USD MILLION)
• TABLE 85. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SPHINCTEROTOMY, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 86. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SPHINCTEROTOMY, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 87. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SPHINCTEROTOMY, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 88. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SPHINCTEROTOMY, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 89. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY THERAPEUTIC SERVICES, 2018-2024 (USD MILLION)
• TABLE 90. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY THERAPEUTIC SERVICES, 2025-2032 (USD MILLION)
• TABLE 91. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY THERAPEUTIC SERVICES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 92. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY THERAPEUTIC SERVICES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 93. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY THERAPEUTIC SERVICES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 94. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY THERAPEUTIC SERVICES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 95. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY THERAPEUTIC SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 96. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY THERAPEUTIC SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 97. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY ENDOSCOPIC MUCOSAL RESECTION, BY REGION, 2018-2024 (USD MILLION)
• TABLE 98. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY ENDOSCOPIC MUCOSAL RESECTION, BY REGION, 2025-2032 (USD MILLION)
• TABLE 99. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY ENDOSCOPIC MUCOSAL RESECTION, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 100. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY ENDOSCOPIC MUCOSAL RESECTION, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 101. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY ENDOSCOPIC MUCOSAL RESECTION, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 102. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY ENDOSCOPIC MUCOSAL RESECTION, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 103. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY ENDOSCOPIC SUBMUCOSAL DISSECTION, BY REGION, 2018-2024 (USD MILLION)
• TABLE 104. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY ENDOSCOPIC SUBMUCOSAL DISSECTION, BY REGION, 2025-2032 (USD MILLION)
• TABLE 105. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY ENDOSCOPIC SUBMUCOSAL DISSECTION, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 106. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY ENDOSCOPIC SUBMUCOSAL DISSECTION, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 107. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY ENDOSCOPIC SUBMUCOSAL DISSECTION, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 108. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY ENDOSCOPIC SUBMUCOSAL DISSECTION, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 109. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY HEMORRHOID LIGATION, BY REGION, 2018-2024 (USD MILLION)
• TABLE 110. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY HEMORRHOID LIGATION, BY REGION, 2025-2032 (USD MILLION)
• TABLE 111. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY HEMORRHOID LIGATION, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 112. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY HEMORRHOID LIGATION, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 113. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY HEMORRHOID LIGATION, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 114. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY HEMORRHOID LIGATION, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 115. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY POLYPECTOMY, BY REGION, 2018-2024 (USD MILLION)
• TABLE 116. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY POLYPECTOMY, BY REGION, 2025-2032 (USD MILLION)
• TABLE 117. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY POLYPECTOMY, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 118. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY POLYPECTOMY, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 119. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY POLYPECTOMY, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 120. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY POLYPECTOMY, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 121. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SCLEROTHERAPY, BY REGION, 2018-2024 (USD MILLION)
• TABLE 122. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SCLEROTHERAPY, BY REGION, 2025-2032 (USD MILLION)
• TABLE 123. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SCLEROTHERAPY, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 124. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SCLEROTHERAPY, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 125. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SCLEROTHERAPY, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 126. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SCLEROTHERAPY, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 127. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
• TABLE 128. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
• TABLE 129. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY COLORECTAL CANCER SCREENING, BY REGION, 2018-2024 (USD MILLION)
• TABLE 130. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY COLORECTAL CANCER SCREENING, BY REGION, 2025-2032 (USD MILLION)
• TABLE 131. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY COLORECTAL CANCER SCREENING, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 132. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY COLORECTAL CANCER SCREENING, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 133. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY COLORECTAL CANCER SCREENING, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 134. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY COLORECTAL CANCER SCREENING, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 135. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 136. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 137. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 138. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 139. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 140. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 141. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY INFLAMMATORY BOWEL DISEASES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 142. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY INFLAMMATORY BOWEL DISEASES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 143. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY INFLAMMATORY BOWEL DISEASES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 144. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY INFLAMMATORY BOWEL DISEASES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 145. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY INFLAMMATORY BOWEL DISEASES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 146. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY INFLAMMATORY BOWEL DISEASES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 147. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY LIVER CIRRHOSIS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 148. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY LIVER CIRRHOSIS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 149. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY LIVER CIRRHOSIS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 150. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY LIVER CIRRHOSIS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 151. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY LIVER CIRRHOSIS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 152. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY LIVER CIRRHOSIS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 153. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY LEVEL OF CARE, 2018-2024 (USD MILLION)
• TABLE 154. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY LEVEL OF CARE, 2025-2032 (USD MILLION)
• TABLE 155. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY OBSERVATION, BY REGION, 2018-2024 (USD MILLION)
• TABLE 156. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY OBSERVATION, BY REGION, 2025-2032 (USD MILLION)
• TABLE 157. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY OBSERVATION, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 158. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY OBSERVATION, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 159. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY OBSERVATION, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 160. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY OBSERVATION, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 161. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SAME-DAY SURGERY, BY REGION, 2018-2024 (USD MILLION)
• TABLE 162. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SAME-DAY SURGERY, BY REGION, 2025-2032 (USD MILLION)
• TABLE 163. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SAME-DAY SURGERY, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 164. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SAME-DAY SURGERY, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 165. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SAME-DAY SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 166. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SAME-DAY SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 167. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY PATIENT DEMOGRAPHIC, 2018-2024 (USD MILLION)
• TABLE 168. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY PATIENT DEMOGRAPHIC, 2025-2032 (USD MILLION)
• TABLE 169. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY ADULTS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 170. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY ADULTS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 171. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY ADULTS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 172. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY ADULTS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 173. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY ADULTS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 174. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY ADULTS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 175. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2024 (USD MILLION)
• TABLE 176. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY GERIATRIC, BY REGION, 2025-2032 (USD MILLION)
• TABLE 177. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY GERIATRIC, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 178. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY GERIATRIC, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 179. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 180. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 181. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
• TABLE 182. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2032 (USD MILLION)
• TABLE 183. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 184. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY PEDIATRIC, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 185. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 186. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 187. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 188. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 189. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY DIAGNOSTIC TESTS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 190. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY DIAGNOSTIC TESTS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 191. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY DIAGNOSTIC TESTS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 192. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY DIAGNOSTIC TESTS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 193. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY DIAGNOSTIC TESTS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 194. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY DIAGNOSTIC TESTS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 195. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY ENDOSCOPY, BY REGION, 2018-2024 (USD MILLION)
• TABLE 196. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY ENDOSCOPY, BY REGION, 2025-2032 (USD MILLION)
• TABLE 197. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY ENDOSCOPY, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 198. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY ENDOSCOPY, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 199. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY ENDOSCOPY, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 200. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY ENDOSCOPY, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 201. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY THERAPEUTIC INTERVENTIONS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 202. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY THERAPEUTIC INTERVENTIONS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 203. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY THERAPEUTIC INTERVENTIONS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 204. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY THERAPEUTIC INTERVENTIONS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 205. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY THERAPEUTIC INTERVENTIONS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 206. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY THERAPEUTIC INTERVENTIONS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 207. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 208. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
• TABLE 209. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY CLINICS & PHYSICIANS' OFFICES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 210. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY CLINICS & PHYSICIANS' OFFICES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 211. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY CLINICS & PHYSICIANS' OFFICES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 212. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY CLINICS & PHYSICIANS' OFFICES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 213. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY CLINICS & PHYSICIANS' OFFICES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 214. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY CLINICS & PHYSICIANS' OFFICES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 215. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 216. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 217. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 218. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 219. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 220. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 221. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY INDEPENDENT ASCS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 222. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY INDEPENDENT ASCS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 223. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY INDEPENDENT ASCS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 224. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY INDEPENDENT ASCS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 225. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY INDEPENDENT ASCS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 226. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY INDEPENDENT ASCS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 227. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY OWNERSHIP, 2018-2024 (USD MILLION)
• TABLE 228. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY OWNERSHIP, 2025-2032 (USD MILLION)
• TABLE 229. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY CORPORATION-OWNED, BY REGION, 2018-2024 (USD MILLION)
• TABLE 230. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY CORPORATION-OWNED, BY REGION, 2025-2032 (USD MILLION)
• TABLE 231. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY CORPORATION-OWNED, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 232. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY CORPORATION-OWNED, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 233. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY CORPORATION-OWNED, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 234. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY CORPORATION-OWNED, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 235. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY FREESTANDING, BY REGION, 2018-2024 (USD MILLION)
• TABLE 236. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY FREESTANDING, BY REGION, 2025-2032 (USD MILLION)
• TABLE 237. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY FREESTANDING, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 238. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY FREESTANDING, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 239. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY FREESTANDING, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 240. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY FREESTANDING, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 241. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY HOSPITAL-AFFILIATED, BY REGION, 2018-2024 (USD MILLION)
• TABLE 242. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY HOSPITAL-AFFILIATED, BY REGION, 2025-2032 (USD MILLION)
• TABLE 243. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY HOSPITAL-AFFILIATED, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 244. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY HOSPITAL-AFFILIATED, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 245. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY HOSPITAL-AFFILIATED, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 246. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY HOSPITAL-AFFILIATED, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 247. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 248. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 249. AMERICAS GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
• TABLE 250. AMERICAS GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
• TABLE 251. AMERICAS GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
• TABLE 252. AMERICAS GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
• TABLE 253. AMERICAS GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY DIAGNOSTIC SERVICES, 2018-2024 (USD MILLION)
• TABLE 254. AMERICAS GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY DIAGNOSTIC SERVI